GLP-1 therapies, or glucagon-like peptide-1 receptor agonists , represent a remarkable development in how we treat type 2 diabetes . These new drugs help imitating the body’s own GLP-1 process, which https://thebookmarknight.com/story21667637/glp-1-a-significant-approach-in-glucose-treatment